Nuclear was Mirion Technologies’s largest product and service line in fiscal 2025, bringing in $374.60M of $925.40M (40%).
| Product and Service | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Nuclear | $254.20M | $291.80M | $316.60M | $374.60M | |||
| Radiological Search, Measurement, & Analysis Systems | — | — | — | — | |||
| Cancer Care | $206.00M | $215.90M | $228.10M | $237.00M | |||
| Reactor Safety & Control Systems | — | — | — | — | |||
| Labs & Research | $103.10M | $122.90M | $131.70M | $122.20M | |||
| Other Research | $88.70M | $101.70M | $112.80M | $117.80M | |||
| Medical | — | — | — | — | |||
| Other Care | $65.80M | $68.60M | $71.60M | $73.80M | |||
| Total | $717.80M | $800.90M | $860.80M | $925.40M |
Mirion Technologies brought in $925.40M from its five product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 7.5% from $860.80M in fiscal 2024. Nuclear was the largest at $374.60M (40.5%), ahead of Cancer Care at $237.00M (25.6%) and Labs & Research at $122.20M (13.2%). The other two lines brought in $191.60M combined.
Compared with fiscal 2024, Nuclear grew fastest, up 18.3% to $374.60M, while Labs & Research fell the most, down 7.2% to $122.20M. From fiscal 2022 to 2025, combined revenue from these lines grew from $717.80M to $925.40M, a compound annual growth rate of 8.8%. Nuclear's share of the total rose from 35.4% to 40.5%.
Nuclear & Safety was Mirion Technologies’s largest segment in fiscal 2025, bringing in $614.60M of $925.40M (66%).
| Segment | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Nuclear & Safety | $446.10M | $516.40M | $561.10M | $614.60M | |||
| Technologies | — | — | — | — | |||
| Industrial | — | — | — | — | |||
| Medical | $271.70M | $284.50M | $299.70M | $310.80M | |||
| Total | $717.80M | $800.90M | $860.80M | $925.40M |
Mirion Technologies brought in $925.40M from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 7.5% from $860.80M in fiscal 2024. Nuclear & Safety was the largest at $614.60M (66.4%), ahead of Medical at $310.80M (33.6%).
Compared with fiscal 2024, Nuclear & Safety grew 9.5% to $614.60M and Medical grew 3.7% to $310.80M. From fiscal 2022 to 2025, combined revenue from these segments grew from $717.80M to $925.40M, a compound annual growth rate of 8.8%. Nuclear & Safety's share of the total rose from 62.1% to 66.4%.
North America was Mirion Technologies’s largest region in fiscal 2025, bringing in $582.20M of $925.40M (63%).
| Geography | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| North America | $462.70M | $512.30M | $542.20M | $582.20M | |||
| Europe | $241.80M | $272.10M | $305.60M | $327.60M | |||
| Asia Pacific | $13.30M | $16.50M | $13.00M | $15.60M | |||
| Total | $717.80M | $800.90M | $860.80M | $925.40M |
Mirion Technologies brought in $925.40M from its three regions in fiscal 2025, the year ended December 31, 2025. That was up 7.5% from $860.80M in fiscal 2024. North America was the largest at $582.20M (62.9%), ahead of Europe at $327.60M (35.4%) and Asia Pacific at $15.60M (1.7%).
Compared with fiscal 2024, North America grew 7.4% to $582.20M and Europe grew 7.2% to $327.60M. From fiscal 2022 to 2025, combined revenue from these regions grew from $717.80M to $925.40M, a compound annual growth rate of 8.8%. North America's share of the total fell from 64.5% to 62.9%.
Mirion Technologies (MIR) reports its revenue by product and service, by segment and by geography. In fiscal 2025, Nuclear was its largest product and service line, bringing in $374.60M (40.5% of the total), followed by Cancer Care at $237.00M (25.6%).
Nuclear was Mirion Technologies' largest product and service line in fiscal 2025, bringing in $374.60M, or 40.5% of the $925.40M total across its five product and service lines.
Nuclear & Safety was Mirion Technologies' largest segment in fiscal 2025, bringing in $614.60M, or 66.4% of the $925.40M total across its two segments.
North America was Mirion Technologies' largest region in fiscal 2025, bringing in $582.20M, or 62.9% of the $925.40M total across its three regions.
Among Mirion Technologies' product and service lines that make up at least 2% of revenue, Nuclear grew fastest in fiscal 2025, up 18.3% from $316.60M to $374.60M.
Every figure comes from Mirion Technologies' annual financial filings, as reported. Each line keeps the name Mirion Technologies gives it, and years follow its fiscal calendar.
Mirion Technologies' revenue by product and service goes back to fiscal 2019, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.